A recent report reveals that human IPF lung myofibroblasts express high levels of ITGA6 in vitro and in vivo and genetic ablation of ITGA6 in collagen-expressing mesenchymal cells protects mice against bleomycin injury-induced experimental lung fibrosis (Chen et al., 2016). The gene discussed is ITGA6; the disease is pulmonary fibrosis.